[Federal Register Volume 75, Number 97 (Thursday, May 20, 2010)]
[Notices]
[Pages 28260-28261]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-12150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 28261]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Reducing Cardiovascular Disease Risk Through 
Treatment of Obstructive Sleep Apnea.
    Date: June 3, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance Harborplace Hotel, 202 East Pratt Street, 
Baltimore, MD 21202.
    Contact Person: David A Wilson, PhD, Scientific Review Officer, 
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7204, Bethesda, MD 20892-7924, 301-435-0299, 
<a href="/cdn-cgi/l/email-protection#56213f3a25393832376416383e3a343f78383f3e78313920"><span class="__cf_email__" data-cfemail="90e7f9fce3fffef4f1a2d0fef8fcf2f9befef9f8bef7ffe6">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Planning Grants for Clinical Trials of Novel 
Therapies in Lung Transplantation.
    Date: June 3, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Keary A Cope, PhD, Scientific Review Officer, 
Office of Scientific Review, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892-7924, 
(301) 435-2222, <a href="/cdn-cgi/l/email-protection#65060a15000e042508040c094b0b0c0d4b020a13"><span class="__cf_email__" data-cfemail="f89b97889d9399b895999194d6969190d69f978e">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Phase II Clinical Trials of Novel Therapies 
for Lung Diseases.
    Date: June 10, 2010.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person:
    YingYing Li-Smerin, MD, PhD, Scientific Review Officer, Office 
of Scientific Review, National Heart, Lung, and Blood Institute, 
National Institutes of Health, 6701 Rockledge Drive, Room 7184, 
Bethesda, MD 20892-7924, 301-435-0277, <a href="/cdn-cgi/l/email-protection#a8c4c1dbc5cddac1c6e8c6c0c4cac186c6c1c086cfc7de"><span class="__cf_email__" data-cfemail="a7cbced4cac2d5cec9e7c9cfcbc5ce89c9cecf89c0c8d1">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Coordination Core for Programs to Increase 
Diversity Among Individuals Engaged in Health-Related Research 
(PRIDE).
    Date: June 16, 2010.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Stephanie J. Webb, PhD, Scientific Review 
Officer, Review Branch/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, 301-
435-0291, <a href="/cdn-cgi/l/email-protection#dcafa8b9acb4bdb2b5b9f2abb9bebe9cb2b5b4f2bbb3aa"><span class="__cf_email__" data-cfemail="13606776637b727d7a763d64767171537d7a7b3d747c65">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Cellular and Molecular Mechanisms of 
Arterial Stiffening and Its Relationship to Development of 
Hypertension.
    Date: June 17, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Robert T. Su, PhD, Scientific Review Officer, 
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7202, Bethesda, MD 20892-7924, 301-435-0297, 
<a href="/cdn-cgi/l/email-protection#1a696f685a777b737634747372347d756c"><span class="__cf_email__" data-cfemail="76050304361b171f1a58181f1e58111900">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Clinical Investigator and Research Scientist 
Career Development Awards.
    Date: June 17-18, 2010.
    Time: 8 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Marriott Crystal City, 2899 Jefferson Davis 
Highway, Arlington, VA 22202.
    Contact Person: Robert Blaine Moore, PhD, Scientific Review 
Officer, Review Branch/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6701 Rockledge Drive, Room 
7213, Bethesda, MD 20892, 301-594-8394, <a href="/cdn-cgi/l/email-protection#573a383825323517393f3b353e79393e3f79303821"><span class="__cf_email__" data-cfemail="5a373535283f381a343236383374343332743d352c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: May 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12150 Filed 5-19-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>